The brain’s susceptibility to metal dysregulation, as seen in Alzheimer’s disease (amyloid plaques enriched with iron and copper) or Parkinson’s disease (α-synuclein aggregation involving iron), suggests an urgent need to understand how selenoproteins contribute to maintaining metal homeostasis and mitigating neurotoxicity. This evidence concerns the gene SELENOS and Parkinson disease.